Page 134 - 南京医科大学学报自然科学版
P. 134

第41卷第6期
               ·912 ·                            南 京    医 科 大 学 学         报                        2021年6月


             [5] BASTA G,DEL TURCO S,MARCHI F,et al. Elevated        es[J]. Indian J Med Res,2010,132:363-378
                   soluble receptor for advanced glycation end product lev⁃  [14] LV P,ZHENG Y,HUANG J,et al. Association of apolipo⁃
                   els in patients with acute coronary syndrome and positive  protein E gene polymorphism with ischemic stroke in cor⁃
                   cardiac troponin I[J]. Coron Artery Dis,2011,22(8):  onary heart disease patients treated with medium⁃intensi⁃
                   590-594                                           ty statins[J]. Neuropsychiatr Dis Treat,2020,16:2459-
             [6] NAKAMURA K,YAMAGISHI S,ADACHI H,et al. Ele⁃         2466
                   vation of soluble form of receptor for advanced glycation  [15] CHAUDHURI J,BAINS Y,GUHA S,et al. The role of ad⁃
                   end products(sRAGE)in diabetic subjects with coronary  vanced glycation end products in aging and metabolic dis⁃
                   artery disease[J]. Diabetes Metab Res Rev,2007,23(5):  eases:bridging association and causality[J]. Cell Metab,
                   368-371                                           2018,28(3):337-352
             [7] 陈    鹏. CTA 在冠状动脉狭窄评估中的应用价值及其                  [16] ZHANG L,BUKULIN M,KOJRO E,et al. Receptor for
                   与斑块病变的关系[J]. 中国老年学杂志,2020,40(9):                  advanced glycation end products is subjected to protein
                   1795-1799                                         ectodomain shedding by metalloproteinases[J]. J Biol
             [8] 中华医学会心血管病学分会介入心脏病学组,中华医                             Chem,2008,283(51):35507-35516
                   学会心血管病学分会动脉粥样硬化与冠心病学组,中                      [17] KALEA A Z,SCHMIDT A M,HUDSON B I. Alternative
                   国医师协会心血管内科医师分会血栓防治专业委员                            splicing of RAGE:roles in biology and disease[J]. Front
                   会,等. 稳定性冠心病诊断与治疗指南[J]. 中华心血管                      Biosci(Landmark Ed),2011,16(1):2756-2770
                   病杂志,2018,46(9):680-694                       [18] OESTERLE A,BOWMAN M A. S100A12 and the S100/
             [9] KOLOVOU G,DASKALOVA D,MIKHAILIDIS D P. Apo⁃         calgranulins:emerging biomarkers for atherosclerosis and
                   lipoprotein E polymorphism and atherosclerosis[J]. Angi⁃  possibly therapeutic targets [J]. Arterioscler Thromb
                   ology,2003,54(1):59-71                            Vasc Biol,2015,35(12):2496-2507
             [10] DHILLON V S,DEO P,CHUA A,et al. Shorter telomere  [19] DEO P,DHILLON V S,CHUA A,et al. APOE ε4 carri⁃
                   length in carriers of APOE⁃ε4 and high plasma concentra⁃  ers have a greater propensity to glycation and sRAGE
                   tion of glucose,glyoxal and other advanced glycation end  which is further influenced by RAGE G82S polymorphism
                   products(AGEs)[J]. J Gerontol A Biol Sci Med Sci,  [J]. J Gerontol A Biol Sci Med Sci,2020,75(10):1899-
                   2020,75(10):1894-1898                             1905
             [11] HOU J,DENG Q,GUO X,et al. Association between apo⁃  [20] PENCINA M J,NAVAR A M,WOJDYLA D,et al. Quan⁃
                   lipoprotein E gene polymorphism and the risk of coronary  tifying importance of major risk factors for coronary heart
                   artery disease in Hakka postmenopausal women in south⁃  disease[J]. Circulation,2019,139(13):1603-1611
                   ern China[J]. Lipids Health Dis,2020,19(1):139  [21] GUTIERREZ⁃MARISCAL F M,CARDELO M P,DE LA
             [12] RATHNAYAKE K M,WEECH M,JACKSON K G,et al.          CRUZ S,et al. Reduction in circulating advanced glyca⁃
                   Impact of the apolipoprotein E(epsilon)genotype on car⁃  tion end products by mediterranean diet is associated
                   diometabolic risk markers and responsiveness to acute  with increased likelihood of type 2 diabetes remission in
                   and chronic dietary fat manipulation[J]. Nutrients,2019,  patients with coronary heart disease:from the cordioprev
                   11(9):2044                                        study[J]. Mol Nutr Food Res,2020:e1901290(2020⁃06⁃
             [13] ANOOP S,MISRA A,MEENA K,et al. Apolipoprotein E    11)[2020⁃12⁃07]. DOI:10.1002/mnfr.201901290
                   polymorphism in cerebrovascular & coronary heart diseas⁃               [收稿日期] 2020-09-13
   129   130   131   132   133   134   135   136   137   138   139